CGEM ▼ -0.5% - Cullinan Therapeutics, Inc. $CGEM - Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio 24-SEP-2026 07:00 AM ET